Serum Institute seeks emergency use for its Covovax vaccine for 12-17 years age group

New Delhi, Feb 21: Serum Institute of India has sought emergency use authorisation from India’s drug regulator for its COVID-19 vaccine Covovax for the 12 to 17 year age group, official sources said on Monday. The government has not
Source: India News, India Breaking News, Latest news headlines in India – Oneindia News